ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272


SEARCH JOBS


Industry
Healthcare

Segment
Pharmaceuticals





 Company News
Astellas Pharma Inc. (ALPMY) Announces Marketing Approval In Japan For XTANDI® (Enzalutamide) Capsules, An Advanced Prostate Cancer Treatment 3/25/2014 6:47:44 AM    More...
Astellas Pharma Inc. (ALPMY) And Daiichi Sankyo, Inc. (4568.t) Form Compound Library Sharing Partnership 3/20/2014 10:13:49 AM    More...
Astellas Pharma Inc. (ALPMY) And Medivation, Inc. (MDVN) Submit Supplemental New Drug Application For XTANDI (Enzalutamide) For Chemotherapy-Naive Advanced Prostate Cancer 3/18/2014 9:57:54 AM    More...
Cumberland Pharmaceuticals (CPIX) Acquires Vaprisol® From Astellas Pharma Inc. (ALPMY) 3/3/2014 11:05:27 AM    More...
FDA Grants Astellas Qualified Infectious Disease Product Designation For Isavuconazole For The Treatment Of Invasive Mucormycosis 2/27/2014 9:55:22 AM    More...
Astellas Pharma Inc. (ALPMY) Ditches AVEO Oncology (AVEO) Pact As Cancer Drug, Tivozanib, Strikes Out Once Again 2/14/2014 7:18:49 AM    More...
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO), Astellas Pharma Inc. (ALPMY) Discontinue Phase 2 Trial Of Tivozanib In Breast Cancer 1/30/2014 7:14:31 AM    More...
Thousands Of Prostate Patients Denied Astellas Pharma Inc. (ALPMY) Drug That Can Extend Life In Watchdog U-Turn 1/28/2014 8:00:19 AM    More...
Astellas Pharma Inc. (ALPMY) Strikes Pact With ClearPath To Build Vaccines Franchise 1/6/2014 6:46:22 AM    More...
Medivation, Inc. (MDVN) And Astellas Pharma Inc. (ALPMY) Initiate Phase 2 Study Of Enzalutamide in Advanced Breast Cancer That Is Estrogen or Progesterone Receptor Positive And HER2 Normal 12/4/2013 10:11:57 AM    More...
12345678910...